Matthias Will

Matthias Will joined Dren Bio as our CMO in October 2021. Dr. Will most recently served as VP of Clinical Development for CRISPR Therapeutics. During his time at CRISPR, he led the development of the allogeneic cell therapy programs targeting CD70 in lymphomas and RCC and NK cell programs in collaboration with NKarta. Prior to joining CRISPR, Dr. Will was in charge of the Clinical Development team at CytomX and in Clinical Development roles of increasing responsibility at Gilead Sciences at Novartis Oncology. Dr. Will began his career at McKinsey & Company after obtaining his Medical Degree at from the Hannover Medical School, Germany.